Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163528 | SCV000214086 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000200538 | SCV000254497 | likely benign | Neurofibromatosis, type 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001553416 | SCV001774278 | uncertain significance | not provided | 2021-10-28 | criteria provided, single submitter | clinical testing | In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Identified in unaffected controls, but not in any cases in a breast cancer study (Momozawa 2018); This variant is associated with the following publications: (PMID: 30287823) |
Sema4, |
RCV000163528 | SCV002527533 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-01 | criteria provided, single submitter | curation |